Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
Clinical trial NCT04074785 · TERMINATED
Trial details
- NCT number
- NCT04074785
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-13
- Primary completion
- 2023-10-16
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.